Search Results - "Ardeshna, K"

CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin’s and aggressive non-hodgkin’s lymphomas by Ganeshan, B., Miles, K. A., Babikir, S., Shortman, R., Afaq, A., Ardeshna, K. M., Groves, A. M., Kayani, I.

“…Objectives The purpose of this study was to investigate the ability of computed tomography texture analysis (CTTA) to provide additional prognostic information…”
Get full text

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial by McMillan, A.K., Phillips, E.H., Kirkwood, A.A., Barrans, S., Burton, C., Rule, S., Patmore, R., Pettengell, R., Ardeshna, K.M., Lawrie, A., Montoto, S., Paneesha, S., Clifton-Hadley, L., Linch, D.C.

“…Outcomes for patients with high-risk diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP chemotherapy are suboptimal but, to date, no alternative regimen…”
Get full text

Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England by Hounsome, L., Eyre, T. A., Ireland, R., Hodson, A., Walewska, R., Ardeshna, K., Chaganti, S., McKay, P., Davies, A., Fox, C. P., Kalakonda, N., Fields, P. A.

“…Background We wished to examine treatment and outcome patterns in older diffuse large B-cell lymphoma (DLBCL) patients, with a focus on the effect of…”
Get full text

Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial by Gleeson, M., Counsell, N., Cunningham, D., Chadwick, N., Lawrie, A., Hawkes, E.A., McMillan, A., Ardeshna, K.M., Jack, A., Smith, P., Mouncey, P., Pocock, C., Radford, J.A., Davies, J., Turner, D., Kruger, A., Johnson, P., Gambell, J., Linch, D.

“…Central nervous system (CNS) relapse of diffuse large B-cell lymphoma (DLBCL) is associated with a dismal prognosis. Here, we report an analysis of CNS relapse…”
Get full text

Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise by Bharucha, T, Rutherford, A, Skeoch, S, Alavi, A, Brown, M, Galloway, J

“…Aim To perform a systematic review, meta-analysis and Delphi exercise to evaluate diagnostic yield of combined 2-[18 F]-fluoro-2-deoxy- d -glucose (FDG)…”
Get full text

Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial by Kühnl, A., Cunningham, D., Counsell, N., Hawkes, E.A., Qian, W., Smith, P., Chadwick, N., Lawrie, A., Mouncey, P., Jack, A., Pocock, C., Ardeshna, K.M., Radford, J., McMillan, A., Davies, J., Turner, D., Kruger, A., Johnson, P.W., Gambell, J., Rosenwald, A., Ott, G., Horn, H., Ziepert, M., Pfreundschuh, M., Linch, D.

“…There is an on-going debate whether 2- or 3-weekly administration of R-CHOP is the preferred first-line treatment for elderly patients with diffuse large…”
Get full text

Haematological malignancy and critical care ‐ new bedfellows? by Parry‐Jones, J., Ardeshna, K.

Get full text

LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA by Caimi, P. F, Ai, W. Z, Alderuccio, J. P., Ardeshna, K. M, Hamadani, M., Hess, B., Kahl, B. S, Radford, J., Solh, M., Stathis, A., Zinzani, P. L., Wang, Y., Qin, Y., Wang, L., Xu, C., Carlo‐Stella, C.

Get full text

TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) by Morschhauser, F., Dahiya, S., Palomba, M. L., Garcia‐Sancho, A. M., Ortega, J. L. Reguera, Kuruvilla, J., Jager, U., Cartron, G., Izutsu, K., Dreyling, M., Kahl, B., Ghesquieres, H., Ardeshna, K., Goto, H., Barbui, A. M., Abramson, J. S., Borchmann, P., Fleury, I., Mielke, S., Farazi, T., Fasan, O., Lymp, J., Vedal, M., Nishii, R., Avilion, A., Papuga, J., Nastoupil, L. J.

Get full text

A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma by Thomson, K J, Kayani, I, Ardeshna, K, Morris, E C, Hough, R, Virchis, A, Goldstone, A H, Linch, D C, Peggs, K S

Get full text

OUTCOME OF LARGE B‐CELL LYMPHOMA PATIENTS FAILING CD19 TARGETED CAR‐T THERAPY by Kuhnl, A., Kirkwood, A. A., O'Reilly, M., Sanderson, R., Tholouli, E., Patel, A., Besley, C., Iyengar, S., Jones, C., Latif, A.‐L., Norman, J., Osborne, W., Collins, G., McMillan, A., Ardeshna, K., Chaganti, S., Menne, T.

Get full text

LOTIS 2 FOLLOW‐UP ANALYSIS: UPDATED RESULTS FROM A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA by Zinzani, P. L., Caimi, P. F., Carlo‐Stella, C., Ai, W., Alderuccio, J. P., Ardeshna, K. M., Hess, B., Kahl, B. S., Radford, J., Solh, M., Stathis, A., Feingold, J., Ungar, D., Qin, Y., He, S., Hamadani, M.

Get full text

A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM by Kothari, J, Foley, M, Peggs, K S, Mackenzie, S, Thomson, K, Morris, E, Ardeshna, K M, Virchis, A E, Linch, D C, Lambert, J

Get full text

Central nervous system chemoprophylaxis in non‐Hodgkin lymphoma: current practice in the UK by Cheung, C. W., Burton, C., Smith, P., Linch, D. C., Hoskin, P. J., Ardeshna, K. M.

“…Summary Central nervous system (CNS) involvement in non‐Hodgkin lymphoma (NHL) is a well‐recognised complication. There is no consensus regarding indications…”
Get full text

REAL WORLD OUTCOMES AND RESPONSES TO SECOND‐LINE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A MULTICENTRE UK STUDY by Shotton, R., Kirkwood, A. A., Northend, M., Fathoala, D., Burton, K., Ferguson, G., Aiken, L., Shrubsole, C., Henry, L., Owen, M., Oliver, R., Martinez‐Calle, N., Etherington, A., Gallop‐Evans, E., Burton, C., Miall, F., Osborne, W., Le Dieu, R., McKay, P., Ardeshna, K., Collins, G. P., Phillips, E.

Get full text

MODIFICATION OF ESCALATED BEACOPP WITH DACARBAZINE SUBSTITUTION REDUCES TOXICITY WHILE MAINTAINING EFFICACY FOR THE TREATMENT OF ADVANCED STAGE HODGKIN LYMPHOMA by Santarsieri, A., Sturgess, K., Brice, P., Menne, T. F., Osborne, W., Creasey, T., Ardeshna, K. M., Behan, S., Bhuller, K., Booth, S., Collins, G. P., Cwynarski, K., Furtado, M., Iyenga, S., Jones, S. G., O'Mahony, D., Martinez‐Calle, N., McKay, P., Nagumantry, S. K., Rudge, J. F., Shah, N., Stafford, G., Sternberg, A., Uttenthal, B. J., McMillan, A. K., Follows, G. A.

Get full text

THALIDOMIDE IN RELAPSED LYMPHOMA: 5 YEARS OF EXPERIENCE FROM SOUTHEND UNIVERSITY HOSPITAL NHS FOUNDATION TRUST by Blacker, E., Laskou, F., Islam, M.A., Ardeshna, K., Kalkur, P., Cervi, P.

Get full text

ACCEPT: A PHASE IB/II COMBINATION OF ACALABRUTINIB WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (R‐CHOP) FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) by Cummin, T.E., Caddy, J., Mercer, K., Maishman, T., Schuh, A., Lopez Pascua, L., Collins, G., McMillan, A., Ardeshna, K., Galanopoulous, A., Burton, C., Barrans, S., Griffiths, G., Johnson, P., Davies, A.J.

Get full text

NCRI PETREA TRIAL: A PHASE 3 EVALUATION OF PET‐GUIDED, RESPONSE‐ADAPTED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, ADVANCED‐STAGE, HIGH‐TUMOUR‐BURDEN FOLLICULAR LYMPHOMA by Pettitt, A.R., Barrington, S., Kalakonda, N., Khan, U.T., Jackson, R., Carruthers, S., Oates, M., Lin, K., Ardeshna, K., Eyre, T., Fox, C.P., Kennedy, B., Linton, K., Malladi, R., Menne, T., Okosun, J., Paneesha, S., Rule, S., Johnston, A., Trotman, J.

Get full text

P1162: ZANUBRUTINIB IN OLDER PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): SUBGROUP ANALYSIS OF THE MAGNOLIA STUDY by Opat, S., Hu, B., Tedeschi, A., Linton, K. M., McKay, P., Chan, H., Jin, J., Sun, M., Sobieraj-Teague, M., Zinzani, P. L., Coleman, M., Browett, P., Ke, X., Portell, C. A., Thieblemont, C., Ardeshna, K., Bijou, F., Walker, P., Hawkes, E. A., Ho, S.-J., Zhou, K.-S., Co, M., Xu, J., Liang, Z., Anderson, J., Tankersley, C., Huang, J., Trotman, J.

Get full text